Integrated Computational Analysis Reveals HOX Genes Cluster as Oncogenic Drivers in Head and Neck Squamous Cell Carcinoma

Recommended

Comparison of Objective Measures of Trismus and Salivation With Patient-Reported Outcomes Following Treatment for Head and Neck Cancer

Abrogation of Rb Tumor Suppression Initiates GBM in Differentiated Astrocytes by Driving a Progenitor Cell Program

EphB4 and EphrinB2 Act in Opposition in the Head and Neck Tumor Microenvironment

Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment

Signal Peptidase Complex Catalytic Subunit SEC11A Upregulation is a Biomarker of Poor Prognosis in Patients with Head and Neck Squamous Cell Carcinoma

Gastrointestinal Endoscopy Performed by Gastroenterologists: Opportunistic Screening Strategy for Newly Diagnosed Head and Neck Cancers

New Research Identifies Potential Drug Treatment for Advanced Eye Cancer

Factors Influencing Outcomes in Selective Neck Dissection in 661 Patients With Head and Neck Squamous Cell Carcinoma

Integrated Computational Analysis Reveals HOX Genes Cluster as Oncogenic Drivers in Head and Neck Squamous Cell Carcinoma

header-info

May. 13, 2022

In this paper, we have identified the differentially expressed HOX genes (DEHGs) using the cancer genome atlas (TCGA) HNSCC datasets.